These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23650116)

  • 1. A pharmacokinetic standard for babies and adults.
    Holford N; Heo YA; Anderson B
    J Pharm Sci; 2013 Sep; 102(9):2941-52. PubMed ID: 23650116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The integration of allometry and virtual populations to predict clearance and clearance variability in pediatric populations over the age of 6 years.
    Edginton AN; Shah B; Sevestre M; Momper JD
    Clin Pharmacokinet; 2013 Aug; 52(8):693-703. PubMed ID: 23588537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid pharmacokinetics in pediatric patients: an overview.
    Jungbluth GL; Welshman IR; Hopkins NK
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S153-7. PubMed ID: 14520140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine pharmacokinetics in pediatric intensive care--a pooled analysis.
    Potts AL; Anderson BJ; Warman GR; Lerman J; Diaz SM; Vilo S
    Paediatr Anaesth; 2009 Nov; 19(11):1119-29. PubMed ID: 19708909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allometric relationships between the pharmacokinetics of propofol in rats, children and adults.
    Knibbe CA; Zuideveld KP; Aarts LP; Kuks PF; Danhof M
    Br J Clin Pharmacol; 2005 Jun; 59(6):705-11. PubMed ID: 15948935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic considerations in pediatric pharmacotherapy.
    Lim SY; Pettit RS
    Am J Health Syst Pharm; 2019 Sep; 76(19):1472-1480. PubMed ID: 31532503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic Considerations in Designing Pediatric Studies of Proteins, Antibodies, and Plasma-Derived Products.
    Mahmood I
    Am J Ther; 2016; 23(4):e1043-56. PubMed ID: 27386959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essentials for starting a pediatric clinical study (1): Pharmacokinetics in children.
    Yokoi T
    J Toxicol Sci; 2009; 34 Suppl 2():SP307-12. PubMed ID: 19571484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Update on the Use of Allometric and Other Scaling Methods to Scale Drug Clearance in Children: Towards Decision Tables.
    van Rongen A; Krekels EH; Calvier EA; de Wildt SN; Vermeulen A; Knibbe CA
    Expert Opin Drug Metab Toxicol; 2022 Feb; 18(2):99-113. PubMed ID: 35018879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric pharmacokinetic data: implications for environmental risk assessment for children.
    Ginsberg G; Hattis D; Miller R; Sonawane B
    Pediatrics; 2004 Apr; 113(4 Suppl):973-83. PubMed ID: 15060190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Children Are Not Small Adults, but Can We Treat Them As Such?
    Krekels EHJ; Calvier EAM; van der Graaf PH; Knibbe CAJ
    CPT Pharmacometrics Syst Pharmacol; 2019 Jan; 8(1):34-38. PubMed ID: 30689298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of morphine dose in humans.
    Holford NH; Ma SC; Anderson BJ
    Paediatr Anaesth; 2012 Mar; 22(3):209-22. PubMed ID: 22212108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of new oral cephalosporins in children.
    Edwards DJ; Stoeckel K
    Chemotherapy; 1992; 38 Suppl 2():2-9. PubMed ID: 1516460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scaling Drug Clearance from Adults to the Young Children for Drugs Undergoing Hepatic Metabolism: A Simulation Study to Search for the Simplest Scaling Method.
    Calvier EAM; Krekels EHJ; Johnson TN; Rostami-Hodjegan A; Tibboel D; Knibbe CAJ
    AAPS J; 2019 Mar; 21(3):38. PubMed ID: 30850923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetic investigation of actinomycin-D in children and young adults.
    Mondick JT; Gibiansky L; Gastonguay MR; Skolnik JM; Cole M; Veal GJ; Boddy AV; Adamson PC; Barrett JS
    J Clin Pharmacol; 2008 Jan; 48(1):35-42. PubMed ID: 18094218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental pharmacology: neonates are not just small adults..
    Allegaert K; Verbesselt R; Naulaers G; van den Anker JN; Rayyan M; Debeer A; de Hoon J
    Acta Clin Belg; 2008; 63(1):16-24. PubMed ID: 18386761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal clearance parameters for PBPK model analysis of early lifestage differences in the disposition of environmental toxicants.
    DeWoskin RS; Thompson CM
    Regul Toxicol Pharmacol; 2008 Jun; 51(1):66-86. PubMed ID: 18433959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonidine disposition in children; a population analysis.
    Potts AL; Larsson P; Eksborg S; Warman G; Lönnqvist PA; Anderson BJ
    Paediatr Anaesth; 2007 Oct; 17(10):924-33. PubMed ID: 17767627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current state of knowledge on age, sex, and their interactions on clinical pharmacology.
    Schwartz JB
    Clin Pharmacol Ther; 2007 Jul; 82(1):87-96. PubMed ID: 17495875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.